News

Physical silver offers lower costs and no dividend, while gold miners provide equity diversification and income. Which metals strategy fits your portfolio?

VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research.

One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.

Both funds charge just 0.03% in expenses, but BND offers broader corporate and government bond exposure while VGIT focuses solely on U.S. Treasuries with lower volatility.

Investors shouldn't conflate the devaluation of fiat currencies with rising Treasury yields.

Global X's midstream fund delivered $2,531 on a $1,000 investment over five years, while Invesco's solar play returned just $565 despite higher fees.

Buying entire baskets of stocks still makes for smart, instant diversification. But don't look past an obvious opportunity by insisting that only marketwide diversification is beneficial.

Things were looking much better a year ago.

Demand for copper is growing rapidly, as it's used in data centers, wind turbines, and electric vehicles.

Value stocks and small-caps could be ready for the spotlight. This low-cost index fund lets you own 834 of these stocks in one ETF.

Tech and AI have dominated the past several years. The next couple of decades could look a lot different.

One of these coins has a fit with its market, and the other hasn't yet found one.

Its worst calendar year since 2012 was a loss of around 5.5%. What has that steadiness cost in the good years?

The fee gap starts at $37 a year. Where does it land after three decades?

Investors are eager to get exposure to certain private companies, and Cathie Wood is offering them a way to do that.

With investors nibbling at Solana ETFs, the Bitwise Solana Staking ETF could be a fund to consider heading into 2027.

If it grows at the rate it's grown over the past three years, your stake could end up worth over $400,000! (But closer to $38,000 is more likely.)

PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.

Some of the world's most important artificial intelligence (AI) stocks are noticeably absent from the S&P 500.

VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.

iShares Silver Trust offers lower fees and $30.5B in assets, while Global X Silver Miners ETF delivers dividend income and operational leverage from mining companies.

IHE concentrates 23.6% in Eli Lilly and delivers 1.4% yield, while XPH spreads risk across 62 holdings with a lower 0.35% expense ratio.

A couple of popular institutional trades are driving much of the purchasing activity.

BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly.

Cathie Wood loves SpaceX, but her firm sold some of its shares this week.